Vitalis Care is nominated for the 2026 Hospice News Product of the Year Award. We'd love your support — every vote counts.
Cast your vote
Vitalis Care is nominated for the 2026 Hospice News Product of the Year Award. We'd love your support — every vote counts.
Not sure which Vitalis Care solution is right for you?
Medicare payment withholding triggered by fraud allegations
A Medicare payment withholding action triggered when a Unified Program Integrity Contractor identifies credible fraud allegations against a hospice, pausing reimbursement pending investigation.
A Medicare payment suspension is the withholding of approved Medicare payments to a provider before a formal overpayment determination, typically triggered by a credible allegation of fraud. It is administered by the Unified Program Integrity Contractor (UPIC) assigned to the provider's jurisdiction and can be imposed without advance notice. A payment suspension freezes revenue; it does not revoke enrollment or terminate the provider.
CMS may suspend Medicare payments under 42 CFR 405.371 when there is reliable information of an overpayment or a credible allegation of fraud (42 CFR 405.371(a)(1)–(2), https://www.ecfr.gov/current/title-42/chapter-IV/subchapter-B/part-405/subpart-C/subject-group-ECFRcb4be12070a402f/section-405.371). A "credible allegation of fraud" is defined as an allegation from any source — hotline tips, claims data mining, audits, civil false claims cases, or law enforcement investigations — that has indicia of reliability, though a fraud hotline tip alone without further evidence does not meet the threshold (42 CFR 405.370(a), https://www.ecfr.gov/current/title-42/chapter-IV/subchapter-B/part-405/subpart-C/subject-group-ECFRcb4be12070a402f/section-405.370). The authority was expanded under the Affordable Care Act of 2010 and codified in final rulemaking in 2011.
CMS may waive advance notice when it determines that notice would put additional Medicare funds at risk (42 CFR 405.372(a)(4)(iii), https://www.ecfr.gov/current/title-42/chapter-IV/subchapter-B/part-405/subpart-C/subject-group-ECFRcb4be12070a402f/section-405.372). In that case, the provider learns of the suspension only after it takes effect. The provider receives 15 business days from receipt of the notice to submit a written rebuttal, which goes to the UPIC (42 CFR 405.372(b), https://www.ecfr.gov/current/title-42/chapter-IV/subchapter-B/part-405/subpart-C/subject-group-ECFRcb4be12070a402f/section-405.372). The UPIC's response to the rebuttal is not an initial determination and is not administratively appealable (42 CFR 405.375(c), https://www.ecfr.gov/current/title-42/chapter-IV/subchapter-B/part-405/subpart-C/subject-group-ECFRcb4be12070a402f/section-405.375). Suspended funds are held in a suspense account — not returned — until the investigation resolves. Suspensions are generally expected to last no longer than 18 months but may be extended if the case is under review by HHS-OIG or if DOJ requests continuation (42 CFR 405.372(d), https://www.ecfr.gov/current/title-42/chapter-IV/subchapter-B/part-405/subpart-C/subject-group-ECFRcb4be12070a402f/section-405.372).
The UPIC for the Western Jurisdiction is Qlarant Integrity Solutions. In April 2026, Qlarant issued Notice of Suspension letters to approximately 447 California hospices and 23 home health agencies, citing credible allegations of fraud based primarily on elevated live discharge rates materially above the national hospice non-death discharge rate of roughly 17–18% [1]. The letters cited an audit window of January 1, 2025 through March 31, 2026, and the suspension was imposed without advance notice. This was the largest single enforcement action against hospice providers to date and was part of a broader DOJ–HHS Task Force effort that included separate federal prosecutions of sham hospice operations in Southern California.
A separate hospice-specific provision also applies: if a hospice fails to timely file an acceptable cap determination report, payment is immediately suspended in whole or in part until the report is filed and accepted, and the rebuttal provisions of § 405.372 do not apply to cap-related suspensions (42 CFR 405.371(e), https://www.ecfr.gov/current/title-42/chapter-IV/subchapter-B/part-405/subpart-C/subject-group-ECFRcb4be12070a402f/section-405.371).
Payment suspension is the hospice enforcement action with the most immediate operational impact: it stops cash flow while enrollment remains active and staffing and patient-care obligations continue. Unlike the enrollment moratorium (which prevents new provider entry) or the SFP (which increases survey frequency), a payment suspension hits revenue without advance notice and the UPIC's rebuttal decision is not administratively appealable. The April 2026 California sweep demonstrated that CMS deploys payment suspensions at scale rather than targeting individual providers; the primary trigger in most suspension letters was an elevated live discharge rate — a single measurable metric derived from claims data. Qlarant's data-mining methodology is not geographically constrained, and the DOJ–HHS Health Care Fraud Task Force has signaled operational expansion beyond the initial California focus. Live discharge rate and non-hospice spending profile are the two metrics most directly associated with the 2026 suspension actions.
It is an allegation from any source — hotline tips, data mining, audits, civil false claims cases, or law enforcement — that has indicia of reliability; a fraud hotline tip alone without further evidence does not qualify (42 CFR 405.370(a), https://www.ecfr.gov/current/title-42/chapter-IV/subchapter-B/part-405/subpart-C/subject-group-ECFRcb4be12070a402f/section-405.370).
Yes — advance notice may be waived when CMS determines that notice would place additional Medicare funds at risk or hinder recovery of an overpayment (42 CFR 405.372(a)(4)(iii), https://www.ecfr.gov/current/title-42/chapter-IV/subchapter-B/part-405/subpart-C/subject-group-ECFRcb4be12070a402f/section-405.372).
No — a payment suspension freezes revenue while the provider remains enrolled and operationally active; an enrollment revocation terminates the provider's ability to bill Medicare entirely (42 CFR 405.371)[2].
The primary allegation in the Qlarant Notice of Suspension letters was an elevated live discharge rate — including transfers, revocations, and "no longer terminal" discharges — materially above the national hospice non-death discharge rate of roughly 17–18%, within an audit window of January 1, 2025 through March 31, 2026 [1].
Vitalis Care is the end-of-life care app that helps hospices deliver compassionate care — while staying on top of schedules, field operations, documentation, compliance, and reimbursement.
Powered By nextbracket.io
